首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   243篇
  免费   32篇
耳鼻咽喉   1篇
儿科学   4篇
妇产科学   4篇
基础医学   41篇
口腔科学   1篇
临床医学   26篇
内科学   66篇
皮肤病学   11篇
神经病学   8篇
特种医学   10篇
外科学   40篇
综合类   5篇
预防医学   29篇
药学   20篇
肿瘤学   9篇
  2022年   2篇
  2021年   10篇
  2020年   4篇
  2019年   11篇
  2018年   11篇
  2017年   4篇
  2016年   2篇
  2014年   3篇
  2013年   3篇
  2012年   13篇
  2011年   10篇
  2010年   8篇
  2009年   3篇
  2008年   9篇
  2007年   12篇
  2006年   8篇
  2005年   15篇
  2004年   5篇
  2003年   10篇
  2002年   16篇
  2001年   14篇
  2000年   16篇
  1999年   7篇
  1998年   5篇
  1997年   2篇
  1996年   4篇
  1995年   3篇
  1993年   3篇
  1992年   6篇
  1991年   6篇
  1990年   8篇
  1989年   6篇
  1988年   2篇
  1987年   2篇
  1986年   2篇
  1985年   3篇
  1984年   1篇
  1982年   1篇
  1980年   1篇
  1979年   3篇
  1978年   3篇
  1977年   2篇
  1976年   3篇
  1975年   1篇
  1974年   1篇
  1973年   4篇
  1972年   1篇
  1971年   2篇
  1970年   1篇
  1968年   1篇
排序方式: 共有275条查询结果,搜索用时 22 毫秒
1.
The progression of 'naive' and 'memory' T-cells and the T-cell receptor Vbeta (TCR Vbeta) repertoire dynamics within the peripheral CD4+ T-cell compartment were studied in individuals following HIV seroconversion. Profound TCR Vbeta repertoire perturbations were observed within the CD4+ T-cell pool in treatment-naive patients regardless of their levels of viremia during the first 6-8 months after seroconversion. The ratio of 'naive' to 'memory' CD4+ T-cells as well as the TCR Vbeta repertoire dynamics did not appear to correlate with absolute numbers of CD4 T-cells.  相似文献   
2.
3.
4.
Martin S. Hirsch, MD; Françoise Brun-Vézinet, MD; Richard T. D'Aquila, MD; Scott M. Hammer, MD; Victoria A. Johnson, MD; Daniel R. Kuritzkes, MD; Clive Loveday, MD, PhD; John W. Mellors, MD; Bonaventura Clotet, MD, PhD; Brian Conway, MD; Lisa M. Demeter, MD; Stefano Vella, MD; Donna M. Jacobsen; Douglas D. Richman, MD

JAMA. 2000;283:2417-2426.

Objective  Assays for drug resistance testing in human immunodeficiency virus type 1 (HIV-1) infection are now available and clinical studies suggest that viral drug resistance is correlated with poor virologic response to new therapy. The International AIDS Society–USA sought to update prior recommendations to provide guidance for clinicians regarding indications for HIV-1 resistance testing.

Participants  An International AIDS Society–USA 13-member physician panel with expertise in basic science, clinical research, and patient care involving HIV resistance to antiretroviral drugs was reconvened to provide recommendations for the clinical use of drug resistance testing.

Evidence and Consensus Process  The full panel met regularly between January and October 1999. Resistance and resistance testing data appearing in the last decade through April 2000 and presentations at national and international research conferences were reviewed. Recommendations and considerations were developed by 100% group consensus, acknowledging that definitive data to support final recommendations are not yet available.

Conclusions  Emerging data indicate that despite limitations, resistance testing should be incorporated into patient management in some settings. Resistance testing is recommended to help guide the choice of new regimens after treatment failure and for guiding therapy for pregnant women. It should be considered in treatment-naive patients with established infection, but cannot be firmly recommended in this setting. Testing also should be considered prior to initiating therapy in patients with acute HIV infection, although therapy should not be delayed pending the results. Expert interpretation is recommended given the complexity of results and assay limitations.

  相似文献   

5.
The aim of this article is to document the incidence and appearances of the pyramidal lobe of the thyroid gland, and discuss the clinical relevance of this entity in sonographic practice. A prospective study was undertaken over a period of 10 months. A total of 416 consecutive patients attending head and neck ultrasound lists were scanned by a single experienced radiologist or an advanced practitioner sonographer. At the time of reporting, the presence of a pyramidal lobe was recorded. The anatomical morphology was classified into five subgroups devised for the purposes of the study. Appearances were documented in both normal and pathological glands. Of the total number of patients scanned, 90 patients were found to have pyramidal lobes, giving an overall incidence of 21%. In all, 51% were found to originate from the right of the isthmus, 46% from the left and 2% from the midline. One patient had two pyramidal lobes. A significant number of patients having routine neck ultrasounds have an incidental finding of a pyramidal lobe. Ultrasound is an effective modality for the demonstration and classification of the pyramidal lobe, as well as identification of pathology. It is important for radiologists to be aware of this normal variation, as it may be the site of primary or recurrent thyroid pathology. Radiologists should report it where relevant to ensure adequate surgical treatment of pathological glands.  相似文献   
6.
7.
In 1996 the International AIDS Society-USA convened an international panel of experts in HIV drug resistance and clinical management to develop guidelines for the clinical use and limitations of resistance testing. Since then the International AIDS Society-USA Resistance Testing Guidelines Panel has developed and regularly published its recommendations. The latest panel recommendations appear in the July 1 issue of Clinical Infectious Diseases. We periodically pose questions to the panel relating to clinical elements of resistance testing that have been collected from HIV practitioners across the nation. We are happy to feature the latest edition in this issue of Topics in HIV Medicine. It is our hope that addressing these issues will help guide your treatment strategy decisions regarding resistance testing.  相似文献   
8.
OBJECTIVE: To determine whether mode of delivery or the use of maternal or neonatal antiretroviral prophylaxis influence the age when HIV-1 can first be detected in infected infants, particularly the probability of detection at birth. METHODS: In a collaboration between four multicentre studies, data on 422 HIV-1 infected infants who were assessed by HIV-1 DNA PCR or cell culture before 14 days of age were analysed. Weibull mixture models were used to estimate the cumulative proportion of infants with detectable levels of HIV-1 according to use of maternal/neonatal antiretroviral therapy (mainly zidovudine monotherapy) and mode of delivery. RESULTS: HIV-1 was detected in 162 infants (38%) when they were first tested, at a median age of 2 days. At birth, it was estimated that 36% [95% confidence interval (CI), 31-41%] of infants have levels of virus that can be detected by DNA PCR or cell culture. This percentage was not associated with either mode of delivery (35% for vaginal delivery versus 40% for cesarean section delivery; P = 0.4) or the use of maternal or neonatal antiretroviral prophylaxis. Among infants with undetectable levels of HIV-1 at birth, the median time to viral detectability was estimated to be 14.8 days (95% CI, 12.9-16.8 days). This time was increased by 15% (95% CI, -11 to 48%; P = 0.3) among infants who were exposed to antiretroviral therapy postnatally compared with infants who were not exposed. No effect was observed for mode of delivery. CONCLUSIONS: The outcome of an early virological test for HIV-1 is thought to be related directly to the timing of transmission and cesarean section delivery primarily reduces the risk of intrapartum transmission. The absence of an association between mode of delivery and viral detectability at birth was therefore unexpected. There was no evidence that foetal or neonatal exposure to prophylactic zidovudine delays substantially the diagnosis of infection, although this cannot be inferred for combination antiretroviral therapy.  相似文献   
9.
Cell lines are traditionally used as tools for in vitro studies of breast cancer. It is highly debatable however, because of the genetic drift that occurs in such long term cultures how representative these cell lines are of breast cancer in vivo. For this reason primary cultures are generally regarded as a better model. Here we have used a primary culture technique (Int. J. Cancer, 66 (1996) 551; Br. J. Cancer, 78 (1998) 1421) to obtain primary breast cancer cells from 13 breast cancer biopsies. We then describe the development and use of methodology to confirm the purity of the cultures. The acquisition of a highly pure population of epithelial cells was confirmed by flow cytometric analysis of intracellular vimentin and cytokeratin 19. The methodology described will have many applications in studies requiring a highly pure population of epithelial breast cancer cells, as well as wide use in other cancers.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号